Veale Clinton G L, Müller Ronel
School of Chemistry and Physics, Pietermaritzburg Campus, University of KwaZulu-Natal, Private Bag X01, Scottsville, 3209, South Africa.
ChemMedChem. 2020 May 19;15(10):809-826. doi: 10.1002/cmdc.202000086. Epub 2020 Apr 9.
Global advancements in biological technologies have vastly increased the variety of and accessibility to bioassay platforms, while simultaneously improving our understanding of druggable chemical space. In the South African context, this has resulted in a rapid expansion in the number of medicinal chemistry programmes currently operating, particularly on university campuses. Furthermore, the modern medicinal chemist has the advantage of being able to incorporate data from numerous related disciplines into the medicinal chemistry process, allowing for informed molecular design to play a far greater role than previously possible. Accordingly, this review focusses on recent highlights in drug-discovery programmes, in which South African medicinal chemistry groups have played a substantive role in the design and optimisation of biologically active compounds which contribute to the search for promising agents for infectious disease.
生物技术的全球进步极大地增加了生物测定平台的种类和可及性,同时增进了我们对可成药化学空间的理解。在南非,这导致目前正在开展的药物化学项目数量迅速增加,尤其是在大学校园。此外,现代药物化学家能够将来自众多相关学科的数据纳入药物化学过程,从而使明智的分子设计能够发挥比以往更大的作用。因此,本综述聚焦于药物发现项目的近期亮点,其中南非药物化学团队在生物活性化合物的设计和优化中发挥了重要作用,这些化合物有助于寻找有前景的传染病治疗药物。